Stock listing

NASDAQ:FUSN Fusion Pharmaceuticals Inc Stock

Follow Fusion Pharmaceuticals Inc into a list and get an email when it puts out news.

Last close · NASDAQ:FUSN

$21.55 USD

Close on Jun 3, 2024 · No longer trades

Jun 26, 2020 to last close +26.8% · weekly closes, Jun 26, 2020 – Jun 3, 2024
Lowest – highest close
$1.98 – $21.55 USDSince Jun 26, 2020 · lowest Nov 7, 2022 · highest Jun 3, 2024

Delisted NASDAQ:FUSN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:FUSN
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Fusion Pharmaceuticals Inc on 6ix

Decks
7 decks · latest Mar 19, 2024

Decks

DeckKindSlidesDate
Merger or Acquisition (March 2024)Merger or acquisition24 slidesMar 19, 2024
Investor Presentation (January 2024)Investor deck26 slidesJan 4, 2024
Technical Presentation (June 2023)Technical23 slidesJun 27, 2023
Merger or Acquisition (February 2023)Merger or acquisition27 slidesFeb 13, 2023
Investor Presentation (June 2022)Investor deck33 slidesJun 9, 2022
Corporate Update (March 2021)Corporate update12 slidesMar 2, 2021
Merger or Acquisition (November 2020)Merger or acquisition26 slidesNov 2, 2020

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Barbara Duncan
Other companies: Halozyme Therapeutics, Inc. (Director · Since at least Feb 3, 2023); Atea Pharmaceuticals, Inc. (Director · Since at least Oct 29, 2020); Ovid Therapeutics Inc. (Director, Chair of the Audit Committee, Member of the Nominating and Corporate Governance Committee · Since at least Jun 14, 2017); Immunomedics Inc (Director · Mar 5, 2019 – Oct 23, 2020 · Past); Jounce Therapeutics Inc (Director · Jan 26, 2017 – May 3, 2023 · Past); Innoviva, Inc. (Director · Nov 18, 2016 – Apr 20, 2017 · Past); Adaptimmune Therapeutics PLC (Director · Jun 23, 2016 – Jul 1, 2022 · Past); Aevi Genomic Medicine LLC (Director · Jul 22, 2015 – Feb 3, 2020 · Past); Intercept Pharmaceuticals Inc (Chief Accounting Officer · Oct 10, 2012 – Oct 3, 2016 · Past)
Director · Oct 30, 2020 – Jun 4, 2024 · Past
Chau Quang Khuong
Other companies: Damora Therapeutics, Inc. (Director · Oct 28, 2020 – Jun 14, 2023 · Past); NextCure, Inc. (Director · May 8, 2019 – Jun 22, 2023 · Past); Inspire Medical Systems, Inc. (Director · May 2, 2018 – Oct 9, 2020 · Past); Synlogic Inc (Director · Aug 28, 2017 – Apr 20, 2021 · Past); Whitehawk Therapeutics, Inc. (Director · Mar 15, 2017 – Jun 18, 2019 · Past); Nabriva Therapeutics AG (Director · Dec 30, 2016 – Jun 23, 2017 · Past); Palvella Therapeutics, Inc. (Director · Jun 29, 2015 – Oct 25, 2017 · Past); Otonomy Inc (Director · Aug 12, 2014 – Jun 21, 2016 · Past)
Director · Jun 25, 2020 – Jun 14, 2023 · Past
Heather Preston
Other companies: Oxford Nanopore Technologies PLC (Non Executive Director · Since at least May 1, 2026); Aligos Therapeutics, Inc. (Director · Since at least Aug 7, 2024); Akouos Inc (Director · Jun 25, 2020 – Nov 30, 2022 · Past); Karuna Therapeutics Inc (Director · Jun 27, 2019 – Jun 24, 2021 · Past); Entasis Therapeutics Holdings Inc (Director · Sep 25, 2018 – Jun 19, 2019 · Past); Albireo Pharma Inc (Director · Nov 3, 2016 – Jan 23, 2017 · Past); Otonomy Inc (Director · Aug 12, 2014 – Jun 11, 2019 · Past); Alder BioPharmaceuticals Inc (Director · May 7, 2014 – Oct 22, 2019 · Past)
Director · Jun 25, 2020 – Jun 14, 2023 · Past
Pablo J. Cagnoni
Other companies: Incyte Corporation (President, Incyte and Global Head of R&D · Since at least Jun 5, 2023); Turmeric Acquisition Corp (Director · Oct 15, 2020 – Oct 15, 2020 · Past); Rubius Therapeutics Inc (Director · Jul 17, 2018 – Feb 1, 2023 · Past); CRISPR Therapeutics AG (Director · Oct 18, 2016 – Nov 19, 2019 · Past); Onyx Pharmaceuticals Inc (EVP, Global R&D and Tech Ops · Mar 11, 2013 – Oct 1, 2013 · Past); Allos Therapeutics Inc (Sr. VP, Chief Medical Officer · Mar 19, 2007 – Sep 30, 2009 · Past); Osi Pharmaceuticals Inc (VP & Chief Medical Officer · Dec 13, 2006 – Dec 13, 2006 · Past)
Director · Jun 25, 2020 – Jun 4, 2024 · Past
David Meek
Other companies: Cullinan Therapeutics, Inc. (Chair of the Nominating and Corporate Governance Committee · Since at least May 15, 2024); uniQure N.V. (Chairman of the Board · Since at least Jun 13, 2018); Entasis Therapeutics Holdings Inc (Director · Jun 19, 2019 – Jul 7, 2022 · Past); Baxalta Inc (EVP and President, Oncology · Jun 30, 2015 – Jun 3, 2016 · Past); Endocyte Inc (Chief Commercial Officer · Aug 3, 2012 – Feb 6, 2014 · Past)
Director · Oct 16, 2023 – Jun 4, 2024 · Past
Jeremy Bender
Other companies: Bicara Therapeutics Inc. (Director · Since at least Jul 28, 2026); Aura Biosciences, Inc. (Director · Since at least Jul 7, 2026); Mereo BioPharma Group plc (Non-Executive Director · Since at least Jan 1, 2024); Day One Biopharmaceuticals Inc (CHIEF EXECUTIVE OFFICER, Director · Since at least May 26, 2021)
Director · Oct 16, 2023 – Jun 4, 2024 · Past
Donald A Bergstrom
Other companies: Relay Therapeutics, Inc. (President, R&D · Since at least Jul 15, 2020); Mersana Therapeutics Inc (Chief Medical Officer · Jun 27, 2017 – Feb 2, 2018 · Past)
Director · Apr 1, 2021 – Jun 4, 2024 · Past
John J Crowley
Other companies: Centessa Pharmaceuticals PLC (Chief Financial Officer · Since at least Jun 10, 2024); Charles River Laboratories International, Inc. (SVP, Chief Accounting Officer · May 24, 2016 – Oct 1, 2016 · Past)
Chief Financial Officer · Jun 25, 2020 – Jun 4, 2024 · Past
Philina Lee
Other companies: DBV Technologies SA (Board Member · Since at least Oct 30, 2025); Blueprint Medicines Corp (Chief Commercial Officer · Since at least Apr 4, 2022)
Director · Feb 11, 2021 – Jun 4, 2024 · Past
Teresa Bitetti
Other companies: Takeda Pharmaceutical Co. Ltd. (President, Global Oncology Business Unit · Since at least Jan 5, 2026); Aura Biosciences, Inc. (Director · Since at least Mar 31, 2025)
Director · Oct 16, 2023 – Jun 4, 2024 · Past
All 19 people
PersonSeat
Christopher P Leamon
Other companies: Endocyte Inc (Vice President of Research · Dec 21, 2011 – Dec 21, 2018 · Past)
Chief Scientific Officer · Nov 1, 2021 – Jun 4, 2024 · Past
James J O'Leary
Other companies: ImmunoGen Inc (Vice President · Nov 7, 2008 – Jul 17, 2014 · Past)
Chief Medical Officer · Jun 25, 2020 – Feb 1, 2022 · Past
Johan Christenson
Other companies: Aprea Therapeutics, Inc. (Director · Oct 2, 2019 – Jun 30, 2020 · Past)
Director · Jun 25, 2020 – Jun 30, 2020 · Past
Steven Gannon
Other companies: Xenon Pharmaceuticals Inc. (Director · Since at least May 21, 2015)
Director · Jun 25, 2020 – Jun 4, 2024 · Past
Damian LambDirector · Jun 25, 2020 – Jun 25, 2020 · Past
Dmitri BobilevChief Medical Officer · Nov 7, 2022 – Jun 4, 2024 · Past
Eric BurakChief Technology Officer · Jun 25, 2020 – Jun 4, 2024 · Past
John ValliantChief Executive Officer, Director · Jun 25, 2020 – Jun 4, 2024 · Past
Mohit RawatPresident & CBO · Sep 27, 2021 – Jun 4, 2024 · Past

Open People

Log in to ask 6ix AI your own questions about Fusion Pharmaceuticals Inc.